Delivery Order SPE2DR25D2001-SPE2DR26FBGA4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,953.63 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open procurement guidelines. The order is scheduled for ultimate completion by June 6, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a contract value of $7,837.15. This is a firm fixed-price delivery order with no set-aside designation, issued under the competitive contracting process. The ultimate completion date is December 5, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $3,977.47. This contract represents a firm fixed-price delivery order under a competitive, non-set-aside procurement and is scheduled for completion by July 25, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office and serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Myrbetriq ER 50 mg tablets (30-count units) with a ceiling value of $3,437.07. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is set for ultimate completion by August 27, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) valued at $6,100.96. This competitively awarded, firm fixed-price delivery order is not set-aside and is scheduled for completion by August 20, 2025. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government, with fulfillment occurring at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $45,927.43. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to be completed by September 16, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $7,226.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among eligible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $16,088.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 9, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $7,602.25 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units). This competitive, firm fixed-price delivery order is scheduled for completion by December 8, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger federal pharmaceutical supply framework, continuing the company's role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $2,524.00. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's larger pharmaceutical supply framework. The order is scheduled for completion by December 1, 2025, and will be fulfilled from AmerisourceBergen's facility in...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBGA4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Myrbetriq ER 25 mg tablets in a 90-tablet quantity, with a contract ceiling value of $15,477.87 and an ultimate completion date of December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. That parent contract serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling the company to deliver a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains. Myrbetriq, a urological medication, represents one of many pharmaceutical products AmerisourceBergen supplies to support Defense Health Agency requirements and other federal healthcare systems through this prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 12/16/25 |